COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,118 Articles (21,576 medRxiv, 7,542 bioRxiv)

Most recent first Previous |  Page 145: Articles 1441-1450  | Next

Gender differences in submission behavior exacerbate publication disparities in elite journals
Basson, I., Ni, C., Badia, G., Tufenkji, N., Sugimoto, C. R., Lariviere, V.
10.1101/2023.08.21.554192 — Posted: 2023-08-25
Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity
Moreno, A., Manning, K., Azeem, M. I., Nooka, A. K., Ellis, M., Manalo, R. J., Switchenko, J. M., Wali, B., Kaufman, J. L., Hofmeister, C. C., Joseph, N. S., Lonial, S., Dhodapkar, K. M., Dhodapkar, M. V., Suthar, M. S.
10.1101/2023.08.17.553767 — Posted: 2023-08-25
Rationally designed multimeric nanovaccines using icosahedral DNA origami for molecularly controlled display of SARS-CoV-2 receptor binding domain
Feng, Q., Cheng, K., Zhang, L., Gao, X., Liang, J., Liu, G., Ma, N., Xu, C., Tang, M., Chen, L., Wang, X., Ma, X., Zou, J., Shi, Q., Du, P., Wang, Q., Nie, G., Zhao, X.
10.1101/2023.08.24.554561 — Posted: 2023-08-24
SARS-CoV-2 Nsp13 is a viral RHIM protein promoting cell death linked to Z-RNA sensing and ZBP1-RIPK3 signaling
Mishra, S., Jain, D., Dey, A. A., Nagaraja, S., Srivastava, M., Khatun, O., Balamurugan, K., Anand, M., Tripathi, S., Ganji, M., Kesavardhana, S.
10.1101/2023.08.23.554434 — Posted: 2023-08-24
Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccination
Wang, P., ZHAO, X.
10.1101/2023.08.22.554373 — Posted: 2023-08-24
Gut microbiome remains stable following COVID-19 vaccination in healthy and immuno-compromised individuals
Boston, R. H., Guan, R., Baier, S., Kalmar, L., Horner, E. C., Beristain-Covarrubias, N., Yam-Puc, J. C., Gerber, P. P., Faria, L., Kuroshchenkova, A., Lindell, A. E., Blasche, S., Correa-Noguera, A., Elmer, A., Saunders, C., Bermperi, A., Jose, S., Kingston, N., COVID-19 BioResource Collaboration, , Grigoriadou, S., Staples, E., Buckland, M., Parkinson, C., Lear, S., Matheson, N. J., Benes, V., Thaventhiran, J. E., Patil, K. R.
10.1101/2023.08.23.554506 — Posted: 2023-08-24
Comparison of SARS-CoV-2 variants in primary human nasal cultures indicates Delta as most cytopathic and Omicron as fastest replicating
Tanneti, N. S., Patel, A. K., Tan, L. H., Marques, A. D., Perera, R. A., Sherrill-Mix, S., Kelly, B. J., Collman, R. G., Rodino, K., Lee, C., Bushman, F. D., Cohen, N. A., Weiss, S. R.
10.1101/2023.08.24.553565 — Posted: 2023-08-24
Deep proteome analysis of time-series human plasma samples applied to Covid-19 antibody test
Fukuda, T., Nakayama, A., Chikaoka, Y., Bando, Y., Kawamura, T.
10.1101/2023.08.23.554537 — Posted: 2023-08-24
Unveiling the Robustness of Machine Learning Models in Classifying COVID-19 Spike Sequences
Ali, S., Chen, P.-Y., Patterson, M.
10.1101/2023.08.24.554651 — Posted: 2023-08-24
Prediction of COVID-19 infection risk using personal mobile location data only
Jang, A., Kim, S., Baek, H., Kim, H., Park, H.-L.
10.1101/2023.08.22.23294419 — Posted: 2023-08-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).